Skip to content

Clinical trials

Phase 3 Hemophilia A trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 3 Country / region: Japan Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20102
20112
20123
20133
20142
20152
20162
20171
20185
20193
20202
20213
20223
20234
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Active, not recruiting7
Recruiting5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S14
Pfizer7
Hoffmann-La Roche6
Genzyme, a Sanofi Company4
Baxalta now part of Shire3
Bioverativ Therapeutics Inc.2
Bioverativ, a Sanofi company2
Bayer1
BioMarin Pharmaceutical1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A43
Hemophilia B10
Hematologic Diseases4
Blood Coagulation Disorders3
Blood Coagulation Disorders, Inherited3
Coagulation Protein Disorders3
Genetic Diseases, Inborn3
Hemorrhage3
Hemorrhagic Disorders3
Genetic Diseases, X-Linked2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.